RecruitingNCT06847542
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
PHASE3 · 250 planned enrolment
- Countries listed
- 13
- Registry update
- September 21, 2026
immortal.lifeExact source-linked program identifier and related public trial registrations.
1 exact source-linked registration. No aliases, synonyms, ownership, or cross-source equivalence are inferred.
PHASE3 · 250 planned enrolment